ITCI - Intra-Cellular Therapies, Inc.
131.87
-0.050 -0.038%
Share volume: 16,062,974
Last Updated: 04-01-2025
Pharmaceutical Products/Pharmaceutical Preparations:
3.26%
PREVIOUS CLOSE
CHG
CHG%
$131.92
-0.05
0.00%
View ratios
| Fiscal Date | 03-31-2024 | 06-30-2024 | 09-30-2024 | 12-31-2024 | |
|---|---|---|---|---|---|
| Fiscal Quarter | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | |
| Report Date | 05-07-2024 | 08-07-2024 | 10-30-2024 | 02-21-2025 | |
| Cash flow financing | 9.989 M | 545.179 M | 6.734 M | 5.606 M | |
| Other financing cash flows | 9.989 M | 2.093 M | 6.734 M | 5.606 M | |
| Cash flow | -7.948 M | 553.487 M | -228.994 M | -157.364 M | |
| Net income | -15.247 M | -16.220 M | -26.324 M | -16.885 M | |
| Depreciation | 132.000 K | 129.000 K | 138.000 K | 109.000 K | |
| Changes in inventories | 499.000 K | 0.000 | 0.000 | 0.000 | |
| Changes in receivables | 0.000 | 0.000 | 0.000 | 0.000 | |
| Investing Cashflow | 16.179 M | 7.766 M | -209.203 M | -149.892 M | |
| Net Borrowings | 0.000 | 0.000 | 0.000 | 0.000 | |
| Investing Activity Other | 0.000 | 0.000 | 0.000 | 0.000 | |
| Dividends Paid | 0.000 | 0.000 | 0.000 | 0.000 | |
| Exchange Rate Effect | 0.000 | 0.000 | 0.000 | 0.000 | |
| Capital Expenditures | 0.000 | 0.000 | 696.000 K | -427.000 K | |
| Cash Change | -7.948 M | 553.487 M | -228.994 M | -157.364 M |